The Observational and Pragmatic Research Institute is proud to announce the launch of the Pragmatic Evaluation of an Improvement Program for People Living with Modifiable High-risk COPD (PREVAIL) study, in collaboration with AstraZeneca and...
Read more
New COVID-19 quality improvement programme available to GP practices across the United Kingdom First-of-its-kind quality improvement programme to exclusively focus on Covid-19 and the management of chronic conditions in the context of a pandemic...
Read more
Bleecker ER, Menzies-Gow A, Price D, Bourdin A, Sweet S, Martin A, Alacqua M, Tran TN. Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management. Am J Respir Crit Care Med. 2020;201:276–93. Steroids, either in the form of...
Read more
Mathioudakis AG, Custovic A, Deschildre A, Price D et al. Research priorities in pediatric asthma: Results of a global survey of multiple stakeholder groups by the Pediatric Asthma in Real Life (PeARL) Think Tank. J Allergy Clin Immunol: In Pract...
Read more
World-leading Singapore research institute, the Observational Pragmatic Research Institute (OPRI), is the largest contributor to the global understanding of inhalers for lung disease and was recently featured in a systematic review about the...
Read more
Professor David Price recently spoke about the management of asthma in different phenotypes at the Asian Pacific Society of Respirology’s Asthma Symposium 2019. While asthma hospitalization and mortality rates have been declining in past years, a...
Read more
A study by OPRI published in NPJ Primary Care Respiratory Medicine found a link between ICS therapy for patients with COPD and the onset of type 2 diabetes and osteoporosis.1 SINGAPORE – A study by OPRI published in NPJ Primary Care Respiratory...
Read more
A study by OPRI describing in details the GOLD group distribution in patients with COPD who started their initial treatment and those with established COPD has been recently published in the Journal EClinicalMedicine.1 The 2019 update of the...
Read more
Washington, 11th July 2019 – Professor David Price, head of The Observational & Pragmatic Research Institute (OPRI; Singapore) and Optimum Patient Care (OPC; Australia and UK), and Primary Care Respiratory Society Professor of Primary Care...
Read more
A study to assess the frequency of CRB65 scoring in patients diagnosed with community-acquired pneumonia (CAP) in primary care has been recently published in the Dove Press journal Pragmatic and Observational Research[1]. Community-acquired...
Read more
Allergic allergy has been increasing in Hong Kong given evolutionary and genetic or environmental factors. Omalizumab, or anti-IgE, is a monoclonal antibody approved for use in Hong Kong, primarily to treat severe persistent allergic asthma...
Read more
The PCRS Respiratory Conference is the UK’s leading respiratory conference. Its aim is to inspire delegates to discover new ways of working with patients and colleagues, helping them to respond positively to the challenges of primary and...
Read more